Indian company Intas Pharmaceuticals has agreed to buy the assets and operations of Actavis Generics in the UK and Ireland from Israeli drugs giant Teva for £60 6 October 2016
Israeli generics juggernaut Teva Pharmaceutical Industries has ended a long-running saga by completing the deal to buy Actavis Generics from Ireland-incorporate 3 August 2016
The US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries’ takeover of the generics arm of Ireland-incorporated Allergan – subject to th 28 July 2016
Israeli generics giant Teva Pharmaceutical Industries (NYSE: TEVA) has attracted more than 30 billion euros ($33.04) of orders for a four billion euros bond sal 22 July 2016
Teva Pharmaceutical Industries will raise between $20 billion and $25 billion in a multi-currency bond sale to pay for its $40.5 billion acquisition of the gene 15 July 2016
The assets of Israeli drugmaker Teva Pharmaceuticals in the UK, Ireland and Iceland have attracted interest from bidders including Netherlands-incorporated Myla 16 May 2016